Lily Chen

Strategic and execution-focused healthcare leader with over 15 years of global experience driving innovation, market expansion, and commercial excellence across the medical technology industry. With a foundation in materials science, I transitioned from engineering to executive leadership in healthcare. Core Strengths: • Global Market Expansion & Commercial Strategy • Cross-Functional Team Leadership & Organizational Growth • Product Innovation & Lifecycle Management • Regulatory & Clinical Strategy (CE Mark, ISO 13485, NMPA) • Stakeholder Engagement (Physicians, Regulators, Distributors) • IPO Readiness & Corporate Governance I co-founded and led a cardiovascular device company from the ground up to IPO registration, scaling the team to 500+ employees and building a global footprint across 30+ countries. As Director of International Marketing & Sales, I created go-to-market strategies, negotiated international partnerships, and built a high-trust network of physicians and distributors worldwide. Notable Achievements: • Pioneered product innovation, designing and commercializing the world's first FFR Microcatheter with MEMS packaging, positioning the company at the forefront of interventional cardiology • Grew the company through major milestones, by building and leading a cross-functional team across R&D, Quality, Regulatory, Production, and International Marketing & Sales • Led the launch and international distribution of innovative cardiovascular products, building global doctor and distributor network and securing first sales • Developed and executed global regulatory and quality strategies, achieving ISO 13485 certification, CE mark and NMPA approvals to enable commercialization in China and Europe within four years • Navigated market disruptions during COVID by digital marketing and expanding product reach to over 30 countries • Initiated a global clinical trial with 2,500 patients across 30+ centers to support market access and real-world evidence generation An MBA at IESE and Kellogg strengthened my financial foundation and strategic leadership, enhancing my ability to lead across functions, regions, and cultures and to deliver patient-centered care. More about me: https://poetsandquants.com/2025/04/25/2025-best-brightest-mba-lili-lily-chen-iese-business-school/ https://blog.iese.edu/mba/navigating-motherhood-and-a-full-time-mba-my-journey-at-iese-and-kellogg/ I’m always open to meaningful conversations with leaders in Pharmaceutical, MedTech, Biotech, Digital Health and investment institutions who are building the future of patient care.